GW Pharmaceuticals SWOT Analysis, Competitors & USP

Posted in Pharma and Healthcare, Total Reads: 3654

SWOT analysis of GW Pharmaceuticals analyses the brand/company with its strengths, weaknesses, opportunities & threats. In GW Pharmaceuticals SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like GW Pharmaceuticals to benchmark its business & performance as compared to the competitors and industry. GW Pharmaceuticals is one of the leading brands in the pharma and healthcare sector. The table below also lists the top GW Pharmaceuticals competitors and elaborates GW Pharmaceuticals market segmentation, target group, positioning & Unique Selling Proposition (USP).

GW Pharmaceuticals SWOT, Competitors, Marketing STP & Brand analysis Table
GW Pharmaceuticals Brand Analysis
Parent Company

GW Pharmaceuticals




Pharma and Healthcare

Tagline/ Slogan



Its MS treatment product

GW Pharmaceuticals STP


Target Group

People suffering from multiple sclerosis, epilepsy and cancer


Focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform

GW Pharmaceuticals SWOT Analysis

Below is the Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis of GW Pharmaceuticals. Strengths are:

1. GW Pharmaceuticals has the only cultivation license in the United Kingdom from the Home Office and theMHRA, to cultivate cannabis from seeds and clones to conduct scientific research concerning the medicinal uses of the plant
2. GW Pharmaceuticals concluded a partnership with Bayer for the distribution of Sativex in North America
3. GW is researching a large number of cannabinoids, each of which has different effects and applications

4.Collaboration with various educational institutes for R&D.

5. Strong expertise in the industry


Here are the weaknesses in the GW Pharmaceuticals SWOT Analysis:

1. Health issues due to side effects of cannabis
2.Human rights issues as cannabis is considered as a harmful drug
3.Legal issues in cultivating medical cannabis

4.Requires very high quality control in cultivating medical cannabis


Following are the Opportunities in GW Pharmaceuticals SWOT Analysis:

1. Its cannabis-based product, Epidiolex, developed for experimental treatment of epilepsy, will undergo stage-two trials in the US in 2014
2. Tie ups with large hospitals can be a huge opportunity
3.Scope of entering into other segments of pharmaceuticals


The threats in the SWOT Analysis of GW Pharmaceuticals are as mentioned:

1.It has only one major drug Sativex, contribute maximum to the revenue
2.Need for continuous innovation
3.Stringent government rules and quality control measures

GW Pharmaceuticals Competition

Below are the top 3 GW Pharmaceuticals competitors:

1.Shire UK
2.Teva UK Limited
3.Meda Pharmaceuticals UK


The brandguide table above concludes the GW Pharmaceuticals SWOT analysis along with its marketing and brand parameters.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to GW Pharmaceuticals. The BrandGuide section covers SWOT Analysis, USP, STP & Competition of more than 6000 brands from over 20 categories.

Search & Explore : BrandGuide

The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only. Utmost care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.

Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin